Population structure of KPC carbapenemase-producing
Anti-Bacterial Agents
/ pharmacology
Bacterial Proteins
/ metabolism
Drug Resistance, Bacterial
/ genetics
Endemic Diseases
Humans
Italy
/ epidemiology
Klebsiella Infections
/ epidemiology
Klebsiella pneumoniae
/ drug effects
Long-Term Care
Microbial Sensitivity Tests
Molecular Epidemiology
Skilled Nursing Facilities
Whole Genome Sequencing
beta-Lactamases
/ metabolism
KPC-type carbapenemases
Klebsiella pneumoniae
molecular epidemiology
sequence type 101
virulence determinants
Journal
Microbial genomics
ISSN: 2057-5858
Titre abrégé: Microb Genom
Pays: England
ID NLM: 101671820
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
entrez:
1
2
2020
pubmed:
1
2
2020
medline:
31
10
2020
Statut:
ppublish
Résumé
In this work, we used a whole-genome sequencing (WGS) approach to study the features of KPC-producing
Identifiants
pubmed: 32003322
doi: 10.1099/mgen.0.000308
pmc: PMC7067035
doi:
Substances chimiques
Anti-Bacterial Agents
0
Bacterial Proteins
0
beta-Lactamases
EC 3.5.2.6
carbapenemase
EC 3.5.2.6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Clin Infect Dis. 2013 Nov;57(9):1246-52
pubmed: 23946222
J Clin Microbiol. 2015 Oct;53(10):3341-4
pubmed: 26202124
J Bacteriol. 2009 Jul;191(14):4492-501
pubmed: 19447910
J Clin Microbiol. 2010 Apr;48(4):1506-7
pubmed: 20200298
Infect Control Hosp Epidemiol. 2012 Dec;33(12):1193-9
pubmed: 23143355
Microb Genom. 2018 Sep;4(9):
pubmed: 29985125
J Hosp Infect. 2018 Sep;100(1):29-34
pubmed: 29879446
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Clin Infect Dis. 2018 Nov 28;67(12):1803-1814
pubmed: 30052813
Front Microbiol. 2018 Jul 16;9:1463
pubmed: 30061868
Gut Pathog. 2012 Jul 16;4(1):7
pubmed: 22800501
J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36
pubmed: 28375512
PLoS One. 2015 Jul 15;10(7):e0132936
pubmed: 26177547
Bioinformatics. 2018 Jan 15;34(2):292-293
pubmed: 29028899
Diagn Microbiol Infect Dis. 2019 Jan;93(1):74-76
pubmed: 30126624
J Antimicrob Chemother. 2019 Mar 1;74(3):577-581
pubmed: 30517666
Microb Genom. 2017 Apr 26;3(4):e000110
pubmed: 28785421
J Antimicrob Chemother. 2016 Dec;71(12):3386-3391
pubmed: 27585968
J Hosp Infect. 2018 Aug;99(4):413-418
pubmed: 29621600
F1000Prime Rep. 2014 Aug 01;6:64
pubmed: 25165563
J Hosp Infect. 2016 Jan;92(1):78-81
pubmed: 26615459
J Infect Dis. 2017 Feb 15;215(suppl_1):S18-S27
pubmed: 28375514
Clin Microbiol Rev. 2017 Apr;30(2):557-596
pubmed: 28275006
APMIS. 2017 May;125(5):491-498
pubmed: 28295617
J Antimicrob Chemother. 2013 Aug;68(8):1932-4
pubmed: 23667172
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
BMC Microbiol. 2015 Nov 09;15(1):260
pubmed: 26552763
Euro Surveill. 2017 Aug 3;22(31):
pubmed: 28797330
Am J Infect Control. 2012 Oct;40(8):760-5
pubmed: 22285709
Clin Infect Dis. 2015 Apr 15;60(8):1153-61
pubmed: 25537877
Microb Genom. 2016 Dec 12;2(12):e000102
pubmed: 28348840
Nat Microbiol. 2019 Nov;4(11):1919-1929
pubmed: 31358985